Long-term Survivors
8
2
3
3
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
12.5%
1 terminated out of 8 trials
75.0%
-11.5% vs benchmark
13%
1 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (8)
Effects of Intraoperative Targeted Temperature Management on Incidence of Postoperative Delirium and Long-term Survival
Perioperative Dexmedetomidine and Long-term Survival After Cancer Surgery
Personalized Massive Online Open Course After Childhood Cancer
Vaginal Dehydroepiandrosterone (DHEA) in Postmenopausal Breast Cancer Survivors on Aromatase Inhibitors
Chemotherapy-Induced Changes to Cognition and DNA in Breast Cancer Survivors
Dexmedetomidine and 5-year Outcome in Elderly Patients After Surgery
Long-term Assessment of Organ Functions Among Survivors of Severe Acute Respiratory Syndrome
Dexmedetomidine and Long-term Outcome in Elderly Patients After Surgery